Navigation Links
Crescendo Biologics Appoints Matthew Roe as Chief Business Officer
Date:6/22/2011

CAMBRIDGE, England, June 21, 2011 /PRNewswire/ --


 

Crescendo Biologics Limited (Crescendo) today announces the appointment of Matthew Roe as Chief Business Officer. Matthew joins Crescendo from Genzyme Corporation where he was Senior Director, Business Development & Licensing.

During a 23-year career at Genzyme, Matthew was active in licensing, alliance management, acquisition, divestment, and sales and marketing, and saw the corporation develop from an entrepreneurial start-up to a leading multi-national biotechnology company. He negotiated and managed multiple agreements for drug delivery technologies in the USA, Europe and Japan and was also a core team member on the divestment of Genzyme's Pharmaceuticals business.

Mike Romanos, CEO of Crescendo said: "Matthew's track record in business development speaks for itself. He has an exceptional depth of experience in business strategy and in implementing agreements across multiple territories. I look forward to working with him as we build on the significant advances we have made at Crescendo and position the Company to deliver real value from its world class, proprietary technology platforms."

Matthew Roe, CBO of Crescendo said: "The monoclonal antibody market is rapidly growing and continues to be a major focus for the pharma industry. Companies are searching for new platforms and approaches, particularly in the area of antibody fragments. Crescendo's technology platform, IP and insight create a strong foundation from which to make a significant impact in the field and I am delighted to be joining the Company's management team as it seeks to grow to become a leader in next-generation antibody therapeutics."

About Crescendo Biologics Ltd

Crescendo Biologics will apply highly innovative antibody fragment technologies to the development of new targeted therapeutics. The Crescendo transgenic mouse platform under development has the potential to rapidly
'/>"/>

SOURCE Crescendo Biologics Limited
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Crescendo Biologics Announces First Triple Knockout Mouse
2. Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
3. Bacterin International Signs Its Second National GPO Contract for Bacterin Biologics and Its First For Wound Drains with ROi
4. Reportlinker Adds Whats Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015
5. Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Submission of Biologics Master File for Recombinant CRM197 to US FDA
6. Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities and Pelvis Market
7. Aperion Biologics Initiates Clinical Trial of Z-Lig™ Device for Anterior Cruciate Ligament Reconstruction
8. New Oral Biologics Delivery Company, Entrega, Announces Strategic Partnership with Pharma
9. Reportlinker Adds Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
10. Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility
11. Reportlinker Adds Immunogenicity to Biologics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2013)... The topics that will be covered ... framework, scrum roles, scrum meetings, scrum artifacts, and scrum ... (8 PDUs) for attending them. , These trainings are ... directors. It is also ideal for those who will ... the software industry or those who want to explore ...
(Date:6/14/2013)... The OpenClinica Global Conference ... this year with Formedix CEO, Mark Wheeldon presenting as ... attendees a deeper insight into the future developments at ... as Formedix to develop innovative solutions. , The conference ... about OpenClinica, hear real-life case studies and discover more ...
(Date:6/14/2013)... EASTON, Mass. , June 14, 2013  Pressure ... announced that it has closed the third and final ... Preferred Stock and Warrants (the "Series J Private Placement").  ... 6 and $156,900 on March 28, 2013), the Company ... Series J Private Placement, slightly over its goal of ...
(Date:6/13/2013)... Eagle Biosciences is proud to ... Calprotectin ELISA assay kit that offers ... (1-2000 µg/g stool). The Calprotectin ELISA assay kit ... human Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP 8/14) ... gastrointestinal assay line which already includes Alpha 1 ...
Breaking Biology Technology:Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 2Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 3Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 2Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 2Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 4Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 5Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2
... requires substantial reform because it too often fails to support ... to new research from the Economic and Social Research Council ... UN, which has designated 2012 the International Year of Sustainable ... Development Mechanism (CDM), under which companies are allocated tradable credits ...
... National Nanotechnology Initiative (NNI) and the Oregon Nanoscience and ... regional, state, and local (RSL) nanotechnology initiatives. ... April 30 Where: Portland, Oregon at the ... OR Who: Leaders of regional, state, and ...
... 2012 The Foundation of UMDNJ, an affiliate of ... biomarkers grant through the Bill & Melinda Gates Foundation,s ... seeks to overcome persistent bottlenecks in creating new tools ... With the grant, Dr. David Alland, ...
Cached Biology Technology:UN emission market needs urgent reform 2Registration now open: 2012 Regional, State, and Local Initiatives in Nanotechnology 2Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant 2Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant 3
(Date:6/17/2013)... their food may turn out to be just as important ... of St. Michael,s Hospital. , The study, led by ... association between poor eating habits in kids ages three to ... cholesterol, putting them at risk for cardiovascular disease later in ... Medical Association Journal today. , "We know that ...
(Date:6/17/2013)... , June 17, 2013 As mobile ... need to secure them grows exponentially, and biometric ... report from Heavy Reading Insider ( ... Heavy Reading ( www.heavyreading.com ). ... the market for biometric authentication on smartphones, analyzing ...
(Date:6/17/2013)... MD (June 17, 2013) The AGA Research Foundation ... in the future of gastroenterology with the 2013 AGA-Horizon ... Student Abstract Prizes. , "In its third year, this ... who are embarking on promising careers in basic and ... of the AGA Research Foundation. "We are extremely proud ...
Breaking Biology News(10 mins):Poor eating behaviors may put preschoolers at risk for later health problems 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3Horizon Pharma Abstract Prizes recognize promising fellows and students 2
... ethanol production has increased dramatically in recent years ... increased. New U.S. government policies require major increases ... a viable cellulosic ethanol industry, expanded grain ethanol ... acres in the near term, with unintended negative ...
... the first pervasive rule of evolution. In ... Academy of Sciences researchers have found evidence which suggests ... Looking back through the last 550 million ... the team investigated the different evolutionary branches of the ...
... Oregon,s Jim Hutchison already holds three patents in the ... in organizations that promote the technology,s potential in materials ... scientist, however, also embraces a strong call for exploring ... be many, and for designing new materials with reduced ...
Cached Biology News:Fueling ethanol production while protecting water quality 2Fueling ethanol production while protecting water quality 3First 'rule' of evolution suggests that life is destined to become more complex 2Think green, UO's Hutchison says, to reduce nanotech hazards 2Think green, UO's Hutchison says, to reduce nanotech hazards 3
...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: